Literature DB >> 28752131

Multiple Administrations of Viral Nanoparticles Alter in Vivo Behavior-Insights from Intravital Microscopy.

Sourabh Shukla1,2, R Dixon Dorand3, Jay T Myers4, Sarah E Woods1, Neetu M Gulati5, Phoebe L Stewart5, Ulrich Commandeur6, Alex Y Huang2,3,4, Nicole F Steinmetz1,2,7,8,9.   

Abstract

Multiple administrations of nanoparticle-based formulations are often a clinical requirement for drug delivery and diagnostic imaging applications. Steady pharmacokinetics of nanoparticles is desirable to achieve efficient therapeutic or diagnostic outcomes over such repeat administrations. While clearance through mononuclear phagocytic system is a key determinant of nanoparticle persistence in vivo, multiple administrations could potentially result in altered pharmacokinetics by evoking innate or adaptive immune responses. Plant viral nanoparticles (VNPs) represent an emerging class of programmable nanoparticle platform technologies that offer a highly organized proteinaceous architecture and multivalency for delivery of large payloads of drugs and molecular contrast agents. These very structural features also render them susceptible to immune recognition and subsequent accelerated systemic clearance that could potentially affect overall efficiency. While the biodistribution and pharmacokinetics of VNPs have been reported, the biological response following repeat administrations remains an understudied area of investigation. Here, we demonstrate that weekly administration of filamentous plant viruses results in the generation of increasing levels of circulating, carrier-specific IgM and IgG antibodies. Furthermore, PVX specific immunoglobulins from the serum of immunized animals quickly form aggregates when incubated with PVX in vitro. Such aggregates of VNP-immune complexes are also observed in the mouse vasculature in vivo following repeat injections when imaged in real time using intravital two-photon laser scanning microscopy (2P-LSM). The size of aggregates diminishes at later time points, coinciding with antibody class switching from IgM to IgG. Together, our results highlight the need for careful in vivo assessment of (viral) nanoparticle-based platform technologies, especially in studying their performance after repeat administration. We also demonstrate the utility of intravital microscopy to aid in this evaluation.

Entities:  

Keywords:  IgM antibody; antibody response; intravital imaging; nanoparticle circulation; repeat administration; viral nanoparticles

Year:  2016        PMID: 28752131      PMCID: PMC5526635          DOI: 10.1021/acsbiomaterials.6b00060

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  68 in total

1.  A phase II study of first-line chemotherapy with weekly carboplatin plus gemcitabine in advanced non-small cell lung cancer.

Authors:  Kiyoshi Mori; Yukari Kamiyama; Hisashi Kasai; Tetsuro Kodama
Journal:  Chemotherapy       Date:  2012-02-23       Impact factor: 2.544

2.  Dynamic visualization of RGD-quantum dot binding to tumor neovasculature and extravasation in multiple living mouse models using intravital microscopy.

Authors:  Bryan Ronain Smith; Zhen Cheng; Abhijit De; Jarrett Rosenberg; Sanjiv Sam Gambhir
Journal:  Small       Date:  2010-10-18       Impact factor: 13.281

Review 3.  PEGylation, successful approach to drug delivery.

Authors:  Francesco M Veronese; Gianfranco Pasut
Journal:  Drug Discov Today       Date:  2005-11-01       Impact factor: 7.851

Review 4.  Applications of viral nanoparticles in medicine.

Authors:  Ibrahim Yildiz; Sourabh Shukla; Nicole F Steinmetz
Journal:  Curr Opin Biotechnol       Date:  2011-05-16       Impact factor: 9.740

5.  Silica-coated Gd(DOTA)-loaded protein nanoparticles enable magnetic resonance imaging of macrophages.

Authors:  Michael A Bruckman; Lauren N Randolph; Neetu M Gulati; Phoebe L Stewart; Nicole F Steinmetz
Journal:  J Mater Chem B       Date:  2015-07-22       Impact factor: 6.331

Review 6.  Chemistry for peptide and protein PEGylation.

Authors:  M J Roberts; M D Bentley; J M Harris
Journal:  Adv Drug Deliv Rev       Date:  2002-06-17       Impact factor: 15.470

7.  Antitumor activity of DNA vaccines based on the human papillomavirus-16 E7 protein genetically fused to a plant virus coat protein.

Authors:  Silvia Massa; Paola Simeone; Antonio Muller; Eugenio Benvenuto; Aldo Venuti; Rosella Franconi
Journal:  Hum Gene Ther       Date:  2008-04       Impact factor: 5.695

Review 8.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

Review 9.  IgG subclasses and allotypes: from structure to effector functions.

Authors:  Gestur Vidarsson; Gillian Dekkers; Theo Rispens
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

Review 10.  Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.

Authors:  Emily M Plummer; Marianne Manchester
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010-09-24
View more
  7 in total

1.  POxylation as an alternative stealth coating for biomedical applications.

Authors:  Herdis Bludau; Anna E Czapar; Andrzej S Pitek; Sourabh Shukla; Rainer Jordan; Nicole F Steinmetz
Journal:  Eur Polym J       Date:  2016-11-05       Impact factor: 4.598

2.  Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Imaging.

Authors:  He Hu; Hema Masarapu; Yuning Gu; Yifan Zhang; Xin Yu; Nicole F Steinmetz
Journal:  ACS Appl Mater Interfaces       Date:  2019-05-10       Impact factor: 9.229

Review 3.  Plant Viruses and Bacteriophage-Based Reagents for Diagnosis and Therapy.

Authors:  Sourabh Shukla; He Hu; Hui Cai; Soo-Khim Chan; Christine E Boone; Veronique Beiss; Paul L Chariou; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2020-09-29       Impact factor: 10.431

Review 4.  The pharmacology of plant virus nanoparticles.

Authors:  Christian Isalomboto Nkanga; Nicole F Steinmetz
Journal:  Virology       Date:  2021-01-28       Impact factor: 3.616

5.  Systemic Infection of Nicotiana benthamiana with Potato virus X Nanoparticles Presenting a Fluorescent iLOV Polypeptide Fused Directly to the Coat Protein.

Authors:  Juliane Röder; Christina Dickmeis; Rainer Fischer; Ulrich Commandeur
Journal:  Biomed Res Int       Date:  2018-02-13       Impact factor: 3.411

Review 6.  Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications.

Authors:  Young Hun Chung; Hui Cai; Nicole F Steinmetz
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

7.  The accelerated blood clearance phenomenon of PEGylated nanoemulsion upon cross administration with nanoemulsions modified with polyglycerin.

Authors:  Yuqing Su; Lirong Wang; Kaifan Liang; Mengyang Liu; Xinrong Liu; Yanzhi Song; Yihui Deng
Journal:  Asian J Pharm Sci       Date:  2017-08-07       Impact factor: 6.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.